(Found: C, 78.23; H, 7.30; N, 8.85. C20H22N2O requires C,
78.40; H, 7.24; N, 9.14%); λmax(C6H6)/nm 361 (log ε 2.52);
νmax(KBr)/cmϪ1 3060, 3020, 2970, 1570, 1470, 1440; δH (CDCl3)
0.26 (3 H, s, endo-CH3), 0.97 (3 H, s, exo-CH3), 1.44 (6 H, m,
CH2), 3.15 (1 H, m, 7a-H), 3.45 (1 H, m, 4a-H), 6.62 (1 H, m, 4Ј-
H), 7.45–7.54 (4 H, m, 5Ј-H and Ph), 7.74 (2 H, m, ortho-
Hphenyl), 7.81 (1 H, m, 2Ј-H); δC(CDCl3) 17.0 (q), 17.8 (q), 25.5
(t), 25.6 (t), 28.7 (t), 48.6 (d), 49.8 (d), 65.2 (s), 94.0 (s), 97.3 (s),
109.6 (d), 121.1 (s), 127.4 (2 × d), 127.7 (d), 128.3 (2 × d), 136.1
(s), 140.6 (d), 143.2 (d).
59 ЊC (decomp.) (Found: C, 75.47; H, 7.26; N, 12.79.
C21H23N3O requires C, 75.65; H, 6.95; N, 12.60%); λmax(C6H6)/
nm 362 (log ε 1.89); νmax(BKr)/cmϪ1 3000, 2920, 1460, 1460,
1280, 1230 (N᎐O); δH (CDCl3) 0.18 (3 H, s, endo-CH3), 1.01 (3 H,
s, exo-CH3), 1.46 (6 H, mc, CH2), 3.40 (1 H, m, 7a-H), 3.48 (1 H,
m, 4a-H), 7.27–7.54 (3 H, m, Ph), 7.67–7.74 (4 H, m, 3Ј-H,
ortho-Hphenyl), 8.33 (2 H, dd, 3J 5.2, 4J 2.0, 2Ј-H); δC(CDCl3) 16.8
(q), 17.8 (q), 25.3 (2 × t), 28.5 (t), 48.9 (d), 49.4 (d), 66.7 (s), 96.3
(s), 99.1 (s), 124.9 (2 × d), 127.4 (2 × d), 128.1 (s), 128.5 (2 × d),
135.4 (s), 136.4 (s), 139.2 (2 × d).
(1á,4á,4aá,7aá)-4,4a,5,6,7,7a-Hexahydro-8,8-dimethyl-1-(N-
oxidopyridinium-3-yl)-4-phenyl-1,4-methano-1H-cyclopenta[d]-
pyridazine (1j). Colourless powder (32.8 mg, 97%), mp 132–
133 ЊC (decomp.) (Found: C, 75.31; H, 7.27; N, 12.87.
C21H23N3O requires C, 75.65; H, 6.95; N, 12.60%); λmax(C6H6)/
nm 361 (log ε 1.38); νmax(KBr)/cmϪ1 3020, 2920, 1570, 1460,
1280 (N᎐O), 1200; δH (CDCl3) 0.19 (3 H, s, endo-CH3), 1.03 (3 H,
s, exo-CH3), 1.54 (6 H, mc, CH2), 3.34 (1 H, dt, 3J 8.7, 3J 6.2, 7a-
Preparation of the azoalkanes 1d–e and h
To a solution of the azoalkanes 1g,i or k (15.6 mg, 50.0 µmol) in
dry diethyl ether (20 cm3) were added 7.17 mg (50.0 µmol) of
70% perchloric acid and the mixture stirred for 15 min at ca.
20 ЊC. The precipitate was then collected by filtration and
washed twice with cold diethyl ether (10 cm3).
(1á,4á,4aá,7aá)-4,4a,5,6,7,7a-Hexahydro-8,8-dimethyl-1-
(pyridinium-4-yl)-4-phenyl-1,4-methano-1H-cyclopenta[d]-
pyridazine perchlorate (1d). Pale-yellow powder (20.0 mg, 96%),
mp 110–111 ЊC (decomp.) (Found: C, 60.31; H, 6.16; N,
10.08. C21H24ClN3O4 requires C, 60.36; H, 5.79; N, 10.06%);
λmax(C6H6)/nm 364 (log ε 2.00); νmax(KBr)/cmϪ1 3200, 3100,
2910, 1480, 1100, 1040; δH (CD3CN) 0.12 (3 H, s, endo-CH3),
1.04 (3 H, s, exo-CH3), 1.49 (6 H, mc, CH2), 3.71 (2 H, mc, 4a-H
and 7a-H), 7.45–7.58 (3 H, m, Ph), 7.72–7.78 (2 H, m, ortho-
Hphenyl), 8.43 (2 H, d, 3J 6.9, 3Ј-H), 8.80 (2 H, br s, 2Ј-H), 9.24 (1
H, br s, NH); δC(CD3CN) 17.0 (q), 18.0 (q), 25.8 (2 × t), 29.3 (t),
49.8 (d), 50.6 (d), 69.1 (s), 97.7 (s), 101.2 (s), 127.1 (2 × d), 128.7
(2 × d), 129.3 (2 × d), 129.5 (2 × d), 135.9 (s), 142.5 (s, 2 × d).
(1á,4á,4aá,7aá)-4,4a,5,6,7,7a-Hexahydro-8,8-dimethyl-1-
(pyridinium-2-yl)-4-phenyl-1,4-methano-1H-cyclopenta[d]-
pyridazine perchlorate (1e). Pale-yellow powder (20.0 mg, 96%),
mp 104–105 ЊC (decomp.) (Found: C, 60.33; H, 6.22; N,
9.88. C21H24ClN3O4 requires C, 60.36; H, 5.79; N, 10.06%);
λmax(C6H6)/nm 363 (log ε 1.99); νmax(KBr)/cmϪ1 3200, 3040,
3020, 2920, 2820, 1580, 1500, 1450, 1080; δH (CD3CN) 0.19 (3
H, s, endo-CH3), 1.12 (3 H, s, exo-CH3), 1.52 (6 H, mc, CH2),
3.74 (2 H, mc, 4a-H and 7a-H), 7.46–7.59 (3 H, m, Ph), 7.76 (2
H, dd, 3J 6.6, 4J 1.7, 2Љ-H), 8.03 (1 H, t, 3J 7.9, 3J 5.0, 5Ј-H), 8.23
(1 H, d, 3J 7.9, 3Ј-H), 8.59 (1 H, t, 3J 7.5, 4J 2.0, 4Ј-H), 8.87 (1 H,
3
3
H), 3.55 (1 H, dt, J 8.9, J 6.2, 4a-H), 7.41–7.51 (4 H, m, Ph),
7.70 (2 H, dt, 3J 6.2, 4J 2.0, ortho-Hphenyl), 7.79 (1 H, ddd, 3J 8.0,
4J 1.6, 5J 1.1, 4Ј-H), 8.27 (1 H, ddd, 3J 6.4, 4J 1.7, 5J 1.0, 6Ј-H),
4
5
8.62 (1 H, t, J 1.4, J 1.1, 2Ј-H); δC(CDCl3) 16.8 (q), 17.8 (q),
25.3 (2 × t), 28.5 (t), 48.7 (d), 49.4 (d), 66.6 (s), 95.3 (s), 99.1 (s),
125.6 (d), 125.7 (d), 127.4 (2 × d), 128.1 (d), 128.5 (2 × d), 135.0
(s), 136.6 (s), 138.1 (d), 138.4 (d).
(1á,4á,4aá,7aá)-4,4a,5,6,7,7a-Hexahydro-8,8-dimethyl-1-(4-
pyridyl)-4-phenyl-1,4-methano-1H-cyclopenta[d]pyridazine-1-
oxide (5i) and (1á,4á,4aá,7aá)-4,4a,5,6,7,7a-hexahydro-8,8-
dimethyl-1-(4-pyridyl)-4-phenyl-1,4-methano-1H-cyclopenta-
[d]pyridazine-4-oxide (5iЈ). To a solution of the azoalkane 1i
(31.2 mg, 100 µmol) in dry methylene chloride (20 cm3) were
added 6.83 mg (110 µmol) of dimethyldioxirane as acetone solu-
tion 10 and stirred for 18 h at ca. 20 ЊC. Removal of the solvent at
water aspirator pressure (ca. 20 ЊC/Torr) afforded the azoxy
derivatives 5i/5iЈ as a colourless powder (33.1 mg, 99%), mp
134–135 ЊC (decomp.) (Found: C, 75.51; H, 7.11; N, 12.74.
C21H23N3O requires C, 75.65; H, 6.95; N, 12.60%); λmax(C6H6)/
nm 362 (log ε 1.89); νmax(KBr)/cmϪ1 3040, 2940, 1560, 1550,
1490 (N᎐O), 1460, 1420; δH of 5i (CDCl3) 0.67 (3 H, s, endo-
CH3), 1.05 (3 H, s, exo-CH3), 1.70 (6 H, mc, CH2), 3.72 (1 H, dt,
3
3
3
3J 8.6, J 6.1, 4a-H), 4.28 (1 H, dt, J 8.6, J 4.9, 7a-H), 7.26–
7.86 (8 H, m, 8 H, arom. H), 8.66 (1 H, dt, 3J 5.2, 4J 2.0, 6Ј-H),
δC of 5i (CDCl3) 17.9 (q), 18.2 (q), 25.6 (t), 26.4 (t), 28.0 (t),
47.1 (d), 48.5 (d), 65.8 (s), 83.3 (s), 102.6 (s), 123.4 (d), 125.7
(2 × d), 127.5 (d), 127.9 (d), 128.0 (2 × d), 134.9 (s), 135.6 (d),
148.8 (d), 150.4 (s); δH of 5iЈ (CDCl3) 0.71 (3 H, s, endo-CH3),
1.12 (3 H, s, exo-CH3), 1.69 (6 H, mc, CH2), 3.89 (1 H, mc, 4a-
H), 4.03 (1 H, mc, 7a-H), 7.26–7.86 (8 H, m, arom. H), 8.67 (1
3
4
dd, J 5.0, J 1.0, 6Ј-H), 9.22 (1 H, br s, NH); δC(CD3CN) 17.0
(q), 18.1 (q), 25.8 (t), 25.9 (t), 29.1 (t), 49.7 (d), 51.0 (d), 69.4 (s),
97.0 (s), 101.7 (s), 126.7 (d), 127.4 (d), 128.7 (2 × d), 129.4 (d),
129.6 (2 × d), 135.5 (s), 144.5 (d), 147.5 (d), 152.6 (s).
(1á,4á,4aá,7aá)-4,4a,5,6,7,7a-Hexahydro-8,8-dimethyl-1-
(pyridinium-3-yl)-4-phenyl-1,4-methano-1H-cyclopenta[d]-
pyridazine perchlorate (1h). Colourless powder (19.6 mg, 94%),
mp 98–99 ЊC (decomp.) (Found: C, 60.19; H, 6.09; N, 9.88.
C21H24ClN3O4 requires C, 60.36; H, 5.79; N, 10.06%);
λmax(C6H6)/nm 363 (log ε 1.99); νmax(KBr)/cmϪ1 3200, 3020,
2920, 2880, 1440, 1080, 1010; δH (CD3CN) 0.14 (3 H, s, endo-
CH3), 1.01 (3 H, s, exo-CH3), 1.46 (6 H, mc, CH2), 3.68 (2 H, mc,
4a-H and 7a-H), 7.45–7.58 (3 H, m, Ph), 7.77 (2 H, dt, 3J 6.6, 4J
3
4
H, dt, J 5.0, J 1.8, 6Ј-H); δC of 5iЈ (CDCl3) 17.9 (q), 18.7 (q),
25.5 (t), 26.2 (t), 28.0 (t), 47.0 (d), 48.9 (d), 66.0 (s), 83.5 (s),
102.8 (s), 122.4 (d), 123.3 (d), 128.3 (2 × d), 128.9 (d), 129.3
(2 × d), 129.6 (s), 136.3 (d), 149.1 (d), 155.9 (s).
5
3
4
4
Acknowledgements
1.7, J 1.7, 2Љ-H), 8.10 (1 H, ddd, J 8.1, J 5.8, J 0.7, 5Ј-H),
4
8.81 (2 H, m, arom. H), 9.13 (2 H, d, J 2.0, 2Ј-H and NH);
We thank the Deutsche Forschungsgemeinschaft and the Fonds
der Chemischen Industrie for generous financial support and
Birgit Beck for technical assistance.
δC(CD3CN) 17.0 (q), 17.8 (q), 25.8 (t), 25.9 (t), 29.2 (t), 49.6 (d),
50.0 (d), 68.0 (s), 96.5 (s), 100.6 (s), 128.3 (d), 128.6 (2 × d),
129.2 (d), 129.5 (2 × d), 136.2 (s), 137.8 (s), 142.2 (d), 143.0 (d),
145.7 (d).
References
Preparation of the azoalkanes 1a and j
1 (a) D. A. Dougherty, in Kinetics and Spectroscopy of Carbenes and
Diradicals, ed. M. S. Platz, Plenum, New York, 1990; (b) J. A. Weil,
J. R. Bolton and J. E. Wertz, Electronic Paramagnetic Resonance:
Elementary Theory and Practical Applications, Wiley, New York,
1994.
2 (a) W. Adam, F. Kita, H. M. Harrer, W. M. Nau and R. Zipf, J. Org.
Chem., 1996, 61, 7056; (b) W. Adam, H. M. Harrer, F. Kita and
W. M. Nau, Pure Appl. Chem., 1997, in the press; (c) W. Adam,
H. M. Harrer, T. Heidenfelder, T. Kammel, F. Kita, W. M. Nau and
C. Sahin, J. Chem. Soc., Perkin Trans. 2, 1996, 2085.
To a solution of the azoalkanes 1g or k (31.2 mg, 100 µmol) in
dry methylene chloride (20 cm3) were added 6.83 mg (110 µmol)
of dimethyldioxirane as acetone solution 10 and stirred for 1 h at
ca. 20 ЊC. Removal of the solvent at water aspirator pressure
(ca. 20 ЊC/15 Torr) afforded the pure derivatives 1a and j.
(1á,4á,4aá,7aá)-4,4a,5,6,7,7a-Hexahydro-8,8-dimethyl-1-(N-
oxidopyridinium-4-yl)-4-phenyl-1,4-methano-1H-cyclopenta[d]-
pyridazine (1a). Colourless powder (33.1 mg, 99%), mp 58–
J. Chem. Soc., Perkin Trans. 2, 1997
693